Your browser doesn't support javascript.
loading
Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
Tischer, Alexander; Brehm, Maria A; Machha, Venkata R; Moon-Tasson, Laurie; Benson, Linda M; Nelton, Katelynn J; Leger, Rachel R; Obser, Tobias; Martinez-Vargas, Marina; Whitten, Steven T; Chen, Dong; Pruthi, Rajiv K; Bergen, H Robert; Cruz, Miguel A; Schneppenheim, Reinhard; Auton, Matthew.
Afiliação
  • Tischer A; Division of Hematology, Departments of Internal Medicine and Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Brehm MA; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Machha VR; Division of Hematology, Departments of Internal Medicine and Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Moon-Tasson L; Division of Hematology, Departments of Internal Medicine and Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Benson LM; Proteomics Core, Department of Biochemistry and Molecular Biology, College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
  • Nelton KJ; Special Coagulation Laboratory, Mayo Medical Laboratories, Mayo Clinic, Rochester, MN, 55905, USA.
  • Leger RR; Special Coagulation Laboratory, Mayo Medical Laboratories, Mayo Clinic, Rochester, MN, 55905, USA.
  • Obser T; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Martinez-Vargas M; Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Whitten ST; Department of Chemistry and Biochemistry, Texas State University, San Marcos, TX, 78666, USA.
  • Chen D; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Pruthi RK; Division of Hematopathology, Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Bergen HR; Proteomics Core, Department of Biochemistry and Molecular Biology, College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
  • Cruz MA; Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Schneppenheim R; Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Auton M; Division of Hematology, Departments of Internal Medicine and Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: auton.matthew@mayo.edu.
J Mol Biol ; 432(2): 305-323, 2020 01 17.
Article em En | MEDLINE | ID: mdl-31628947
ABSTRACT
Von Willebrand factor (VWF), an exceptionally large multimeric plasma glycoprotein, functions to initiate coagulation by agglutinating platelets in the blood stream to sites of vascular injury. This primary hemostatic function is perturbed in type 2 dysfunctional subtypes of von Willebrand disease (VWD) by mutations that alter the structure and function of the platelet GPIbα adhesive VWF A1 domains. The resulting amino acid substitutions cause local disorder and misfold the native structure of the isolated platelet GPIbα-adhesive A1 domain of VWF in both gain-of-function (type 2B) and loss-of-function (type 2M) phenotypes. These structural effects have not been explicitly observed in A1 domains of VWF multimers native to blood plasma. New mass spectrometry strategies are applied to resolve the structural effects of 2B and 2M mutations in VWF to verify the presence of A1 domain structural disorder in multimeric VWF harboring type 2 VWD mutations. Limited trypsinolysis mass spectrometry (LTMS) and hydrogen-deuterium exchange mass spectrometry (HXMS) are applied to wild-type and VWD variants of the single A1, A2, and A3 domains, an A1A2A3 tridomain fragment of VWF, plasmin-cleaved dimers of VWF, multimeric recombinant VWF, and normal VWF plasma concentrates. Comparatively, these methods show that mutations known to misfold the isolated A1 domain increase the rate of trypsinolysis and the extent of hydrogen-deuterium exchange in local secondary structures of A1 within multimeric VWF. VWD mutation effects are localized to the A1 domain without appreciably affecting the structure and dynamics of other VWF domains. The intrinsic dynamics of A1 observed in recombinant fragments of VWF are conserved in plasma-derived VWF. These studies reveal that structural disorder does occur in VWD variants of the A1 domain within multimeric VWF and provides strong support for VWF misfolding as a result of some, but not all, type 2 VWD variants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Estrutura Secundária de Proteína / Doença de von Willebrand Tipo 2 / Deficiências na Proteostase Limite: Humans Idioma: En Revista: J Mol Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Estrutura Secundária de Proteína / Doença de von Willebrand Tipo 2 / Deficiências na Proteostase Limite: Humans Idioma: En Revista: J Mol Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos